Bioventus (BVS) Depreciation & Amortization (CF) (2020 - 2026)

Bioventus (BVS) has reported Depreciation & Amortization (CF) for 7 consecutive years, with $10.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Depreciation & Amortization (CF) fell 9.16% year-over-year to $10.9 million; the trailing twelve-month figure through Jun 2026 stood at $45.2 million (down 6.89% YoY), and the FY2025 full-year result was $47.0 million, down 5.13% from the prior year.
• Depreciation & Amortization (CF) eased to $10.9 million in Q2 2026 per BVS's latest filing, from $11.2 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $16.9 million in Q4 2022 and bottomed at $10.9 million in Q2 2026.
• Historically, Depreciation & Amortization (CF) has averaged $12.9 million across 5 years, with a median of $12.4 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Depreciation & Amortization (CF) jumped 73.71% in 2022, then decreased 28.46% in 2024.
• Over 5 years, Depreciation & Amortization (CF) stood at $16.9 million in 2022, then fell by 26.43% to $12.5 million in 2023, then dropped by 0.48% to $12.4 million in 2024, then dropped by 5.73% to $11.7 million in 2025, then dropped by 6.4% to $10.9 million in 2026.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $10.9 million, $11.2 million, and $11.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.